Grants for Public And State Controlled Institutions Of Higher Education

This funding opportunity supports a wide range of research projects aimed at advancing medical knowledge and improving health, available to various organizations including universities, nonprofits, and businesses.

This funding opportunity supports researchers investigating how HIV-related immune and metabolic changes increase the risk of tuberculosis and hepatitis B in individuals living with HIV.

This funding opportunity supports innovative research projects that explore and address disparities in substance use and racial equity, inviting a diverse range of applicants, including universities, nonprofits, and government entities.

This funding opportunity supports researchers at various institutions to conduct basic experimental studies involving human participants, aimed at advancing our understanding of fundamental biological and behavioral processes.

This grant provides access to specialized resources and expertise for researchers developing gene-based therapies for ultra-rare neurological and neuromuscular diseases, helping them advance their projects toward regulatory approval.

This funding opportunity supports innovative researchers in the U.S. who are tackling significant challenges in diabetes, metabolic diseases, digestive disorders, and nutrition, with the goal of advancing groundbreaking scientific understanding and treatment.

This funding opportunity supports innovative and high-risk research projects in biomedical, behavioral, or clinical fields, aimed at early-stage discoveries and methodologies that could lead to significant advancements.

This funding opportunity supports projects that promote historical awareness and public engagement around shared U.S. and Luxembourg history, particularly focusing on World War II, with an emphasis on youth education and remembrance of the Holocaust.

This funding opportunity supports K-12 schools, nonprofit arts organizations, and individual artists in providing professional arts experiences to students, enhancing their exposure to performing, literary, and visual arts.

This funding opportunity supports researchers conducting innovative basic science studies involving human participants to explore fundamental biological and behavioral processes without focusing on product development or clinical outcomes.

This funding opportunity supports U.S. and Luxembourgish organizations in initiatives that strengthen security and defense collaboration, focusing on NATO, countering misinformation, and enhancing cybersecurity efforts.

This grant provides funding to state and local governments, nonprofits, and Native organizations for the preservation and restoration of historic sites that reflect the early history of the United States, in honor of its 250th anniversary.

This funding opportunity supports innovative research to understand how changes in the immune and metabolic systems due to HIV infection increase the risk of tuberculosis and hepatitis B virus, targeting researchers and institutions focused on infectious diseases and immunology.

This grant provides funding for small-scale research projects that can be completed within two years, supporting innovative studies and methodologies in health and biological sciences by eligible institutions and organizations.

This funding opportunity supports independent research projects in health-related fields for a wide range of eligible applicants, including universities, nonprofits, and small businesses, without allowing clinical trials.

This grant provides funding for innovative and high-risk research projects in biomedical, behavioral, or clinical fields, aimed at early-stage ideas that could lead to significant advancements.

This funding opportunity provides financial support for early-stage researchers from diverse backgrounds to conduct independent studies on communication disorders, including hearing and speech issues, with a focus on addressing significant scientific and clinical challenges.

This funding opportunity provides financial support for research and development of gene-based therapies targeting ultra-rare neurological and neuromuscular disorders, aimed at advancing them toward clinical trials.

This funding opportunity supports innovative, early-stage research involving human participants to advance biomedical and clinical science, targeting a wide range of eligible applicants including universities, nonprofits, and small businesses.

This funding opportunity provides financial support for small-scale research projects in various fields, aimed at institutions and organizations that can complete the work within two years without conducting clinical trials.